Page 4 - Neuropace Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NeuroPace, Inc (NASDAQ:NPCE) Major Shareholder Orbimed Advisors Llc Sells 24,609 Shares

NeuroPace, Inc. (NASDAQ:NPCE – Get Free Report) major shareholder Orbimed Advisors Llc sold 24,609 shares of the firm’s stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $14.05, for a total value of $345,756.45. Following the completion of the transaction, the insider now owns 3,459,113 shares of […]

United statesLeerink partnrsWells fargo companyMorgan stanleyBarclays plcOrbimed advisors llcCantor fitzgeraldCitigroup incKent lake capitalNeuropace incGet free reportAdvisors llcLake capitalNeuropace daily

NeuroPace, Inc (NASDAQ:NPCE) Receives $15 67 Consensus Target Price from Analysts

NeuroPace, Inc. (NASDAQ:NPCE – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month target […]

United statesMartha morrellLeerink partnrsGeode capital managementNeuropace company profileSecurities exchange commissionWells fargo companyCitigroup incBarclays plcOrbimed advisors llcRenaissance technologiesSusquehanna international groupNeuropace incCantor fitzgeraldGet free reportStreet capital

Contrasting Akili (NASDAQ:AKLI) & NeuroPace (NASDAQ:NPCE)

Contrasting Akili (NASDAQ:AKLI) & NeuroPace (NASDAQ:NPCE)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesMountain viewAkili incNeuropace incGet free reportGiven akiliPatient remote monitorAkili daily

NeuroPace, Inc (NASDAQ:NPCE) Major Shareholder Sells $6,692,916 51 in Stock

NeuroPace, Inc. (NASDAQ:NPCE – Get Free Report) major shareholder Orbimed Advisors Llc sold 461,899 shares of the stock in a transaction dated Thursday, April 11th. The shares were sold at an average price of $14.49, for a total value of $6,692,916.51. Following the completion of the sale, the insider now directly owns 3,542,068 shares of […]

United statesLeerink partnrsNeuropace company profileMorgan stanleyWells fargo companySecurities exchange commissionMillennium managementCantor fitzgeraldRenaissance technologiesOrbimed advisors llcNantahala capital managementNeuropace incGet free reportExchange commissionSpace trading downCapital management

Implantable Neurostimulators Market Set to Witness Explosive Growth by 2033

According to Regional Research Reports,

United statesYogesh singhBoston scientific corporationNevro corpNeuropace incRegional researchSynapse biomedical incNeurostimulators market setWitness explosive growthRegional research reportsGlobal implantable neurostimulators marketImplantable neurostimulators marketCompound annual growth rateJude medicalPress releasePress releases